Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gross Profit | $561.3M | $623.3M | $663.4M | $712.9M | $818.1M | $922.3M | $1,038.7M | $1,188.8M | $1,405.0M | $1,523.1M | $1,697.3M | $1,876.5M | $2,166.3M | $2,560.0M | $2,783.4M | $3,233.6M | $3,305.7M | $3,983.6M | $4,302.0M | $4,625.0M |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Edwards Lifesciences Corporation's last 12-month Gross Profit is $4,570.8M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Edwards Lifesciences Corporation's Gross Profit growth was 0.7%. The average annual Gross Profit growth rates for Edwards Lifesciences Corporation have been 10.7% over the past three years, 8.2% over the past five years.
Over the last year, Edwards Lifesciences Corporation's Gross Profit growth was 0.7%, which is higher than industry growth of 0.0%. It indicates that Edwards Lifesciences Corporation's Gross Profit growth is Good.